(Q39040906)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

title

Clinical Pharmacokinetics and Pharmacodynamics of Atezolizumab in Metastatic Urothelial Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

0 references

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

author name string

M Stroh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

H Winter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

M Marchand

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

L Claret

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

S Eppler

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

J Ruppel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

O Abidoye

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

S L Teng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

W T Lin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

S Dayog

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

J Jin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

S Girish

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

English

0 references

publication date

9 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

30 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

page(s)

305-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

30 March 2020

cites work

1 reference

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

21 January 2018

1 reference

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

21 January 2018

1 reference

Antibodies to watch in 2016.

21 January 2018

1 reference

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

Phase I dose-finding study of monotherapy with atezolizumab, an engineered immunoglobulin monoclonal antibody targeting PD-L1, in Japanese patients with advanced solid tumors

21 January 2018

1 reference

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor.

21 January 2018

1 reference

Challenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue

21 January 2018

1 reference

A guide to rational dosing of monoclonal antibodies

21 January 2018

1 reference

Oncology meets immunology: the cancer-immunity cycle

21 January 2018

1 reference

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming

21 January 2018

1 reference

Monoclonal antibody pharmacokinetics and pharmacodynamics

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CPT.587

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27981577%20AND%20SRC:MED&resulttype=core&format=json

30 March 2020

1 reference